Sign in

CIK 0001388320

  • Non-accelerated filer
  • Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880378336
Phone
+1 646-677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-14 David Matthew T Chief Financial Officer Grant or award +250,000 250,000
2026-10-14 David Matthew T Chief Financial Officer Grant or award · Stock Option (right to purchase) +250,000 250,000
2026-09-02 Nicholson, C. David Director Grant or award +62,800 63,300
2026-09-02 Nicholson, C. David Director Grant or award · Stock Option (Right to Buy) +94,200 94,200
2026-09-02 Shetty Ajit Director Grant or award +61,600 62,357
2026-09-02 Shetty Ajit Director Grant or award · Stock Option (Right to Buy) +92,400 92,400
2026-09-02 Almenoff June Sherie Director Grant or award 10b5-1 +18,000 18,000
2026-09-02 Almenoff June Sherie Director Grant or award · Stock Option (Right to Buy) 10b5-1 +27,000 27,000
2026-09-02 SETH SANDESH Chief Executive Officer Grant or award +753,600 938,081
2026-09-02 SETH SANDESH Chief Executive Officer Grant or award +1,027,274 1,965,355
2026-09-02 SETH SANDESH Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,130,400 1,130,400
2026-09-02 Steinhart Richard I Director Grant or award +62,800 63,116
2026-09-02 Steinhart Richard I Director Grant or award · Stock Option (Right to Buy) +94,200 94,200
2026-09-02 Chell Jeffrey W. Director Grant or award +61,600 61,600
2026-09-02 Chell Jeffrey W. Director Grant or award · Stock Option (Right to Buy) +92,400 92,400
2025-08-18 SETH SANDESH Chief Executive Officer Shares withheld for taxes −120,900 $1.71 $207K 184,481
2025-03-31 Steinhart Richard I Director Returned to the company · Stock Option (Right to Buy) −2,500 0
2025-03-31 Steinhart Richard I Director Returned to the company · Stock Option (Right to Buy) −2,500 0
2025-03-31 Steinhart Richard I Director Returned to the company · Stock Option (Right to Buy) −2,500 0
2025-03-31 Steinhart Richard I Director Returned to the company · Stock Option (Right to Buy) −8,333 0

Page 1 of 16 · 316 trades